TC 2216
Latest Information Update: 21 Apr 2008
At a glance
- Originator Targacept
- Class Antidepressants; Anxiolytics
- Mechanism of Action Nicotinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 08 Jan 2007 Phase-I clinical trials in Anxiety disorders in Europe (PO)
- 08 Jan 2007 Phase-I clinical trials in Depression in Europe (PO)